Placenta
Volume 28, Issue 2 , Pages 97-106 , February 2007

High Glucose Alters Proteoglycan Expression and the Glycosaminoglycan Composition in Placentas of Women with Gestational Diabetes Mellitus and in Cultured Trophoblasts

  • C.-P. Chen

      Affiliations

    • Division of High Risk Pregnancy, Mackay Memorial Hospital, Taipei, Taiwan
    • Mackay Medicine, Nursing and Management College, Taipei, Taiwan
    • ,
  • S.-C. Chang

      Affiliations

    • Graduate Institute of Biomedical Materials, Taipei Medical University, 250 Wu-Hsing Street, Taipei 110, Taiwan
    • ,
  • W.-C. Vivian Yang

      Affiliations

    • Graduate Institute of Biomedical Materials, Taipei Medical University, 250 Wu-Hsing Street, Taipei 110, Taiwan
    • Corresponding Author InformationCorresponding author. Tel.: +886 2 27361661x5208; fax: +886 2 86638631.

,Accepted 14 February 2006.

References 

  1. Makhseed MA, Ahmed MA, Musini VM. Impaired gestational glucose tolerance. Its effect on placental pathology. Saudi Med J. 2004;25:1241–1244
  2. Evers IM, Nikkels PG, Sikkema JM, Visser GH. Placental pathology in women with type 1 diabetes and in a control group with normal and large-for-gestational-age infants. Placenta. 2003;24:819–825
  3. Coughlan MT, Vervaart PP, Permezel M, Georgiou HM, Rice GE. Altered placental oxidative stress status in gestational diabetes mellitus. Placenta. 2004;25:78–84
  4. Jansson T, Ekstrand Y, Bjorn C, Wennergren M, Powell TL. Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes. 2002;51:2214–2219
  5. Desoye G, Shafrir E. Placental metabolism and its regulation in health and diabetes. Mol Aspects Med. 1994;15:505–682
  6. Jones CJ, Fox H. Placental changes in gestational diabetes. An ultrastructural study. Obstet Gynecol. 1976;48:274–280
  7. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem. 1998;67:609–652
  8. Hocking AM, Shinomura T, McQuillan DJ. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol. 1998;17:1–19
  9. Yang W-CV, Su T-H, Yang Y-C, Chang S-C, Chen C-Y, Chen C-P. Altered perlecan expression in placental development and gestational diabetes mellitus. Placenta 2005;26:780-88.
  10. Lysiak JJ, Hunt J, Pringle GA, Lala PK. Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta. 1995;16:221–231
  11. Li D, Clark CC, Myers JC. Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J Biol Chem. 2000;275:22339–22347
  12. Leushner JR, Tevaarwerk GJ, Clarson CL, Harding PG, Chance GW, Haust MD. Analysis of the collagens of diabetic placental villi. Cell Mol Biol. 1986;32:27–35
  13. Rukosuev VS. Immunofluorescent localization of collagen types I, III, IV, V, fibronectin, laminin, entactin, and heparan sulphate proteoglycan in human immature placenta. Experientia. 1992;48:285–287
  14. Achur RN, Valiyaveettil M, Alkhalil A, Ockenhouse CF, Gowda DC. Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta. J Biol Chem. 2000;275:40344–40356
  15. Muhlhauser J, Marzioni D, Morroni M, Vuckovic M, Crescimanno C, Castellucci M. Codistribution of basic fibroblast growth factor and heparan sulfate proteoglycan in the growth zones of the human placenta. Cell Tissue Res. 1996;285:101–107
  16. Iozzo RV, San Antonio JD. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest. 2001;108:349–355
  17. Iozzo RV, Cohen IR, Grassel S, Murdoch AD. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J. 1994;302(Pt 3):625–639
  18. Amenta PS, Gay S, Vaheri A, Martinez-Hernandez A. The extracellular matrix is an integrated unit: ultrastructural localization of collagen types I, III, IV, V, VI, fibronectin, and laminin in human term placenta. Coll Relat Res. 1986;6:125–152
  19. San Martin S, Zorn TM. The small proteoglycan biglycan is associated with thick collagen fibrils in the mouse decidua. Cell Mol Biol (Noisy-le-grand). 2003;49:673–678
  20. Wiberg C, Heinegard D, Wenglen C, Timpl R, Morgelin M. Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. J Biol Chem. 2002;277:49120–49126
  21. Bollineni JS, Alluru I, Reddi AS. Heparan sulfate proteoglycan synthesis and its expression are decreased in the retina of diabetic rats. Curr Eye Res. 1997;16:127–130
  22. Vogl-Willis CA, Edwards IJ. High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells. Biochim Biophys Acta. 2004;1672:36–45
  23. Menne J, Park JK, Boehne M, Elger M, Lindschau C, Kirsch T, et al. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. Diabetes. 2004;53:2101–2109
  24. Otsuji T, McLeod DS, Hansen B, Lutty G. Immunohistochemical staining and morphometric analysis of the monkey choroidal vasculature. Exp Eye Res. 2002;75:201–208
  25. Witmer AN, van den Born J, Vrensen GF, Schlingemann RO. Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies. Curr Eye Res. 2001;22:190–197
  26. Ebara T, Conde K, Kako Y, Liu Y, Xu Y, Ramakrishnan R, et al. Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. J Clin Invest. 2000;105:1807–1818
  27. Klein DJ, Cohen RM, Rymaszewski Z. Proteoglycan synthesis by bovine myocardial endothelial cells is increased by long-term exposure to high concentrations of glucose. J Cell Physiol. 1995;165:493–502
  28. Conde-Knape K. Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications. Diabetes Metab Res Rev. 2001;17:412–421
  29. American College of Obstetricians and Gynecologists. Diabetes and pregnancy technical bulletin no. 20; 1994.
  30. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685
  31. Fink L, Seeger W, Ermert L, Hanze J, Stahl U, Grimminger F, et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med. 1998;4:1329–1333
  32. Doolittle MH, Martin DC, Davis RC, Reuben MA, Elovson J. A two-cycle immunoprecipitation procedure for reducing nonspecific protein contamination. Anal Biochem. 1991;195:364–368
  33. Mogyorosi A, Ziyadeh FN. Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose. Am J Physiol. 1998;275:F827–F832
  34. Wahab NA, Parker S, Sraer JD, Mason RM. The decorin high glucose response element and mechanism of its activation in human mesangial cells. J Am Soc Nephrol. 2000;11:1607–1619
  35. Templeton DM, Fan MY. Posttranscriptional effects of glucose on proteoglycan expression in mesangial cells. Metabolism. 1996;45:1136–1146
  36. Urban JP, Hall AC, Gehl KA. Regulation of matrix synthesis rates by the ionic and osmotic environment of articular chondrocytes. J Cell Physiol. 1993;154:262–270
  37. Chen J, Baer AE, Paik PY, Yan W, Setton LA. Matrix protein gene expression in intervertebral disc cells subjected to altered osmolarity. Biochem Biophys Res Commun. 2002;293:932–938
  38. Ishihara H, Warensjo K, Roberts S, Urban JP. Proteoglycan synthesis in the intervertebral disk nucleus: the role of extracellular osmolality. Am J Physiol. 1997;272:C1499–C1506
  39. Hadad SJ, Michelacci YM, Schor N. Proteoglycans and glycosaminoglycans synthesized in vitro by mesangial cells from normal and diabetic rats. Biochim Biophys Acta. 1996;1290:18–28
  40. Kofoed-Enevoldsen A, Eriksson UJ. Inhibition of N-acetylheparosan deacetylase in diabetic rats. Diabetes. 1991;40:1449–1452
  41. Yard B, Feng Y, Keller H, Mall C, van Der Woude F. Influence of high glucose concentrations on the expression of glycosaminoglycans and N-deacetylase/N-sulphotransferase mRNA in cultured skin fibroblasts from diabetic patients with or without nephropathy. Nephrol Dial Transplant. 2002;17:386–391
  42. Marano CW, Szwergold BS, Kappler F, Brown TR, Matschinsky FM. Human retinal pigment epithelial cells cultured in hyperglycemic media accumulate increased amounts of glycosaminoglycan precursors. Invest Ophthalmol Vis Sci. 1992;33:2619–2625
  43. Parthasarathy N, Spiro RG. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes. 1982;31:738–741
  44. Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Kidney Int. 1992;41:1070–1080
  45. Whinna HC, Choi HU, Rosenberg LC, Church FC. Interaction of heparin cofactor II with biglycan and decorin. J Biol Chem. 1993;268:3920–3924
  46. Delorme MA, Xu L, Berry L, Mitchell L, Andrew M. Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placenta. Thromb Res. 1998;90:147–153
  47. Kolm V, Sauer U, Olgemooller B, Schleicher ED. High glucose-induced TGF-beta 1 regulates mesangial production of heparan sulfate proteoglycan. Am J Physiol. 1996;270:F812–F821
  48. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature. 1992;360:361–364
  49. Mogyorosi A, Ziyadeh FN. What is the role of decorin in diabetic kidney disease?. Nephrol Dial Transplant. 1999;14:1078–1081

PII: S0143-4004(06)00039-7

doi: 10.1016/j.placenta.2006.02.009

Placenta
Volume 28, Issue 2 , Pages 97-106 , February 2007

Article Tools

* Image Usage & Resolution